Skip to main content
. 2010 Dec 22;5(12):e15737. doi: 10.1371/journal.pone.0015737

Table 2. Relative hazards of risk factors for breast cancer-specific death.

Features Number (%) hazard ratio (95% CI) p-Value
Menopause
Pre- 142 (44) 1.000
Post- 181 (56) 0.871 (0.479–1.584) 0.6506
anti-Estrogen therapy
none 85 (26) 1.000
performed 238 (74) 0.920 (0.472–1.792) 0.8063
Chemotherapy
none 179 (55) 1.000
performed 144 (45) 5.000 (2.39810.418) <0.0001
Radiation
none 108 (33) 1.000
performed 215 (67) 0.571 (0.313–1.044) 0.0685
T grade: tumor size
≤T1 138 (43) 1.000
T2≤ 185 (57) 4.167 (1.8559.346) 0.0005
Nodes
negative 210 (66) 1.000
positive 110 (34) 4.082 (1.9806.993) <0.0001
Stage: TNM class
≤IIA 228 (71) 1.000
IIB≤ 92 (29) 3.704 (2.0086.803) <0.0001
ER
positive 187 (58) 1.000
negative 136 (42) 3.206 (1.6946.070) 0.0003
PR
positive 170 (53) 1.000
negative 153 (47) 6.562 (2.91914.751) <0.0001
HER2
negative 290 (90) 1.000
positive 33 (10) 2.151 (0.997–4.630) 0.0507
Triple Negative
others 236 (73) 1.000
triple negative 87 (27) 4.149 (2.2717.579) <0.0001
p53
normal 243 (75) 1.000
abnormal 80 (25) 1.737 (0.928–3.254) 0.0843
RB1
positive 307 (95) 1.000
negative 16 (5) 5.325 (2.35312.049) <0.0001
RB1CC1
positive 224 (69) 1.000
negative 99 (31) 3.373 (1.8406.185) <0.0001
RB1CC1/RB1/p53
normal 168 (52) 1.000
abnormal 155 (48) 7.385 (3.1166.185) <0.0001

The Cox proportional hazard regression model was used to evaluate the effects of clinico- pathological parameters on disease-specific-survival (DSS) with 95% confidence interval (95% CI). p-value <0.05, statistically significant. DSS intervals were used as the indicator for the relative-hazards.